当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析 - 资产负债表

华熙生物

(688363)

  

流通市值:159.72亿  总市值:159.72亿
流通股本:4.82亿   总股本:4.82亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金824,963,095.86857,780,607.041,003,660,402.23994,984,838.22
  交易性金融资产187,416,378.86289,831,960.8660,964,738.0633,291,542.26
  应收票据及应收账款585,346,658.46561,185,118.29598,000,775.94564,465,173.49
        应收账款585,346,658.46561,185,118.29598,000,775.94564,465,173.49
  应收款项融资171,000969,099.6910,017,662.642,318,998
  预付款项171,385,863.01148,762,762.57128,630,457.692,480,960.68
  其他应收款合计39,279,753.9940,480,660.9746,767,656.4642,264,918.66
        应收股利-1,092,816--
  存货858,804,031.38881,118,196.65929,577,340.77980,621,587.19
  一年内到期的非流动资产32,345,00032,135,00031,925,00031,715,000
  其他流动资产38,832,404.3136,062,065.6751,984,680.8842,849,920.28
  流动资产合计2,738,544,185.872,848,325,471.742,861,528,714.582,784,992,938.78
非流动资产:
  长期股权投资587,546,530.29573,942,355.68426,156,469.22418,353,990.6
  其他权益工具投资66,649,260.3567,531,930.4185,052,086.8358,620,808.96
  其他非流动金融资产93,291,677.795,651,932.6392,525,007.3793,160,070.41
  固定资产3,385,519,715.373,446,374,978.533,497,348,730.163,537,504,718.71
  在建工程550,392,134.31498,804,982.87446,203,902.18438,519,020.24
  使用权资产70,108,942.4686,775,175.2796,464,233.1278,531,987.49
  无形资产513,720,863.19518,184,115.95512,220,165.21517,620,302.65
  商誉171,022,471.9171,022,471.9171,022,471.9177,624,403.47
  长期待摊费用134,533,752.62141,693,305.86149,689,063.85155,123,070.57
  递延所得税资产351,780,576.29349,393,486.43336,140,744.56335,557,908.46
  其他非流动资产89,463,712.583,283,374.8975,654,400.8596,898,104.22
  非流动资产合计6,014,029,636.986,032,658,110.425,888,477,275.255,907,514,385.78
  资产总计8,752,573,822.858,880,983,582.168,750,005,989.838,692,507,324.56
流动负债:
  短期借款246,603,610.2216,328,325.18160,082,456.0692,887,687.73
  应付票据及应付账款558,313,242.88641,491,151.04602,067,242.84668,094,083.52
  其中:应付票据-46,000,00051,000,00011,550,000
        应付账款558,313,242.88595,491,151.04551,067,242.84656,544,083.52
  合同负债90,558,450.2686,933,190.9870,439,734.957,771,749.74
  应付职工薪酬103,791,826.4119,538,727.82145,231,069.32140,811,910.27
  应交税费64,843,839.0859,575,129.9470,826,908.7576,790,250.2
  其他应付款合计31,098,268.72121,704,980.7136,200,209.0835,053,603.62
        应付股利1,918,012.1192,806,925.871,918,012.111,918,012.11
  一年内到期的非流动负债62,266,670.4577,593,421.68100,625,690.19114,317,184.65
  其他流动负债3,010,087.444,877,967.1825,872,249.24,280,076.53
  流动负债合计1,160,485,995.431,328,042,894.531,211,345,560.341,190,006,546.26
非流动负债:
  长期借款129,000,000135,864,562.568,740,096.9594,663,333.34
  租赁负债50,724,182.0952,422,277.4164,870,650.2839,507,878.67
  递延收益267,835,153.11237,305,905.61242,296,708.06248,941,995.77
  递延所得税负债2,891,289.73,009,684.963,129,061.764,240,551.13
  非流动负债合计450,450,624.9428,602,430.48379,036,517.05387,353,758.91
  负债合计1,610,936,620.331,756,645,325.011,590,382,077.391,577,360,305.17
所有者权益(或股东权益):
  实收资本(或股本)481,678,242481,678,242481,678,242481,678,242
  资本公积3,849,649,216.673,849,649,216.673,849,649,216.673,849,649,216.67
  减:库存股219,947,377.83219,947,377.83219,947,377.83219,947,377.83
  其他综合收益-40,106,495.49-22,632,086.7914,124,546.9134,652,359.21
  盈余公积253,808,683.26253,808,683.26253,808,683.26253,808,683.26
  未分配利润2,781,014,496.22,747,713,477.332,750,467,595.482,685,812,855.88
  归属于母公司股东权益合计7,106,096,764.817,090,270,154.647,129,780,906.497,085,653,979.19
  少数股东权益35,540,437.7134,068,102.5129,843,005.9529,493,040.2
  股东权益合计7,141,637,202.527,124,338,257.157,159,623,912.447,115,147,019.39
  负债和股东权益合计8,752,573,822.858,880,983,582.168,750,005,989.838,692,507,324.56
公告日期2026-10-302026-08-282026-04-302026-04-23
审计意见(境内)标准无保留意见
TOP↑